HIGHLIGHTS
- who: Alessandro Agnarelli et al. from the Department of Biochemistry and Biomedicine, School of Life Sciences, University of Sussex, Brighton , QG, UK have published the research: The Inhibitory Properties of a Novel, Selective LMTK3 Kinase Inhibitor, in the Journal: (JOURNAL)
- what: The authors report the inhibitory properties of another compound (C36) against LMTK3, further supporting the rationale that the development and optimization of LMTK3 inhibitors can have prospective value to cancer patients. Taken together, the authors report the identification of a novel LMTK3 inhibitor (C36), displaying a high in_vitro selectivity profile. The authors report a . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.